Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hims & Hers vs Vital Edge

Hims & Hers
Graded #36

Higher grade

vs+16
Vital Edge
Graded #235

Lower grade

The verdict

Hims & Hers takes it — 81/100 to 65/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +45
82
37
Dose & formulationVital Edge +10
78
88
Clinical oversightVital Edge +4
82
86
Labs & monitoringHims & Hers +27
80
53
FulfillmentHims & Hers +12
84
72
Contract termsHims & Hers +25
80
55
Hims & Hers · left barVital Edge · right bar

The numbers

MetricHims & HersVital Edge
WeighScore81/10065/100
GradeB−C
Scorecard rank#36#235
Semaglutide$199/mo$350/mo (compounded)
TirzepatideNot disclosed$450/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny
Vital Edge

Graded #235 · C

Strengths

  • Transparent flat monthly pricing published on-site — consult, medication, and shipping all included
  • Broad menu: compounded semaglutide/tirzepatide, compounded oral capsules from $199/mo, plus brand-name Ozempic, Wegovy, Mounjaro and Rybelsus
  • LegitScript-certified (seal #43281221)
  • Flat fee with no upcharge as your dose increases
  • Compounded oral GLP-1 capsules available for needle-free dosing

Where it loses points

  • Compounded injectable pricing ($350 semaglutide / $450 tirzepatide) runs above the lowest-cost telehealth options
  • No compounding pharmacy partner named on the site
  • No named medical director or prescribing clinicians
  • State availability not published — only a nationwide virtual-care claim
  • Small, locally-rooted operation with a limited public track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard